|
CHEMBL3837
|
P07711
|
Cathepsin L |
99.58%
|
96.61%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.56%
|
98.95%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
98.65%
|
97.25%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
98.56%
|
96.09%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
98.48%
|
98.94%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
98.08%
|
98.33%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
97.95%
|
96.67%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
97.69%
|
96.85%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
97.29%
|
93.56%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
96.80%
|
97.43%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
96.78%
|
96.95%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
96.20%
|
100.00%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
95.73%
|
92.38%
|
|
CHEMBL321
|
P14780
|
Matrix metalloproteinase 9 |
95.61%
|
92.12%
|
|
CHEMBL3468
|
P55210
|
Caspase-7 |
95.39%
|
95.68%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
95.04%
|
91.19%
|
|
CHEMBL333
|
P08253
|
Matrix metalloproteinase-2 |
94.96%
|
96.31%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
94.77%
|
94.66%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
94.49%
|
94.00%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
94.31%
|
99.77%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
94.24%
|
98.10%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
94.17%
|
97.21%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
94.17%
|
96.03%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
93.44%
|
100.00%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
93.17%
|
97.64%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
92.77%
|
97.50%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
92.72%
|
98.89%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
92.55%
|
97.14%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
92.45%
|
100.00%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
92.25%
|
95.38%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
91.70%
|
96.67%
|
|
CHEMBL4461
|
Q9NTG7
|
NAD-dependent deacetylase sirtuin 3 |
91.31%
|
94.36%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
91.01%
|
97.09%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
90.56%
|
96.47%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
90.20%
|
97.47%
|
|
CHEMBL4361
|
Q07820
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
89.64%
|
95.52%
|
|
CHEMBL5966
|
P55899
|
IgG receptor FcRn large subunit p51 |
88.88%
|
90.93%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
88.20%
|
94.33%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
88.19%
|
98.24%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
87.09%
|
88.42%
|
|
CHEMBL3830
|
Q2M2I8
|
Adaptor-associated kinase |
86.76%
|
83.10%
|
|
CHEMBL2095194
|
P08709
|
Coagulation factor VII/tissue factor |
86.63%
|
99.17%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
86.61%
|
95.89%
|
|
CHEMBL2073
|
P07947
|
Tyrosine-protein kinase YES |
85.85%
|
83.14%
|
|
CHEMBL3880
|
P07900
|
Heat shock protein HSP 90-alpha |
84.47%
|
96.21%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
84.24%
|
89.50%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
84.02%
|
98.75%
|
|
CHEMBL2094135
|
Q96BI3
|
Gamma-secretase |
83.85%
|
98.05%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
83.49%
|
96.90%
|
|
CHEMBL2664
|
P23526
|
Adenosylhomocysteinase |
83.42%
|
86.67%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
83.33%
|
90.71%
|
|
CHEMBL4462
|
Q8IXJ6
|
NAD-dependent deacetylase sirtuin 2 |
83.31%
|
90.24%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
83.11%
|
97.23%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
82.82%
|
93.00%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
82.76%
|
97.50%
|
|
CHEMBL3351
|
Q13085
|
Acetyl-CoA carboxylase 1 |
82.47%
|
93.04%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
82.46%
|
99.17%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
82.36%
|
97.50%
|
|
CHEMBL4015
|
P41597
|
C-C chemokine receptor type 2 |
82.26%
|
98.57%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
82.20%
|
95.71%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
81.91%
|
100.00%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
81.56%
|
96.28%
|
|
CHEMBL5469
|
Q14289
|
Protein tyrosine kinase 2 beta |
81.51%
|
91.03%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
81.49%
|
95.50%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
81.25%
|
95.00%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
81.09%
|
99.35%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
80.93%
|
95.89%
|
|
CHEMBL3691
|
Q13822
|
Autotaxin |
80.75%
|
96.39%
|
|
CHEMBL255
|
P29275
|
Adenosine A2b receptor |
80.41%
|
98.59%
|
|
CHEMBL1873
|
P00750
|
Tissue-type plasminogen activator |
80.36%
|
93.33%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
80.01%
|
95.27%
|